12Visits(Average 8)
100%Visits with a flag raised(Average 37%)
92%Telehealth visits(Average 64%)
12Controlled prescriptions(Average 2)
1Providers seen
92%Follow-up scheduled rate
50%Care coordination rate (with PCP)
Warning Signs visits with each kind
Corporate Refill Policy12
ID/Licensure Verification11
Cross-State Licensure11
Visits with any warning sign12 of 12
Controlled Medications 12 prescriptions, all Schedule II
Lisdexamfetamine 70 mg
3
Amphetamine-Dextroamphetamine 20 mg
3
Lisdexamfetamine 30 mg
3
Methylphenidate 10 mg
2
Methylphenidate 36 mg ER
1
Diagnoses 12 visits
- ADHD, predominantly hyperactive type100%
Patient and Provider States 12 of 12 visits crossed state lines
NYPatient in New York
AZEddie Torreloma, NP in Arizona
0 of 12 visits were with a provider who has a license on record in New York.
Visit Checks
License to practice
0%
of Karen's visits were with a provider who has a license on record in New York.
Identity verified
83%
of Karen's visits have a record that the patient's identity was checked.
PDMP check rate
100%
of Karen's controlled prescriptions have a record that the state prescription database was checked first.
Check-in with other doctors
50%
of Karen's visits have a record of checking with the patient's regular doctor.
Follow-up scheduled
92%
of Karen's visits ended with a follow-up visit on the calendar.
Consent to treatment
100%
of Karen's visits have a record that the patient agreed to treatment.
Visit History
Show visits
| Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 30 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Jan 14, 2025 |
| Telehealth visit with Eddie Torreloma, NP Methylphenidate 36 mg ER · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Nov 23, 2024 |
| Telehealth visit with Eddie Torreloma, NP Methylphenidate 10 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Nov 15, 2024 |
| Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 30 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Oct 29, 2024 |
| Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 70 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Sep 28, 2024 |
| Telehealth visit with Eddie Torreloma, NP Amphetamine-Dextroamphetamine 20 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Sep 7, 2024 |
| Telehealth visit with Eddie Torreloma, NP Amphetamine-Dextroamphetamine 20 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Aug 30, 2024 |
| Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 70 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Jul 7, 2024 |
| Telehealth visit with Eddie Torreloma, NP Methylphenidate 10 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | May 30, 2024 |
| Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 30 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Mar 4, 2024 |
| Office visit with Eddie Torreloma, NP Amphetamine-Dextroamphetamine 20 mg · Corporate Refill Policy | Feb 11, 2024 |
| Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 70 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill Policy | Feb 3, 2024 |
Showing the latest 10 of 12 visits
